Table 4.
Pregnancy and neonatal outcomes
| Outcomes | Number (%) of patients |
|---|---|
| Pregnancy outcomes: | |
| Continued pregnancy | 16 (8.6%) |
| Miscarriage | 3 (1.6%) |
| Intrauterine fetal death (IUFD) | 1 (0.54%) |
| Delivered live birth (including two twin birth) | 165 (89%) |
| Gestational age at delivery, weeks | |
| Median (interquartile range) | 38 (36–39) |
| 27–32+ 6 weeks | 2 (1.2%) |
| 33–36+ 6 weeks | 42 (25.5%) |
| ≥ 37 weeks | 121 (73.3%) |
| Mode of delivery | |
| C-section | 79 (47.8%) |
| Elective (repeat/maternal request) | 35 (44.3%) |
| Emergency | 10 (12.6%) |
| Maternal Hypoxia | 1 (1.2%) |
| Preeclampsia | 11 (13.9%) |
| Failed induction/ failure to progress | 13 (16.4%) |
| Fetal distress | 9 (11.4%) |
| Type of anesthesia during C-section | |
| • General | 9 (11.4%) |
| • Spinal | 70 (88.6%) |
| Vaginal delivery | 86 (52.1%) |
| Instrumental delivery | 0 |
| Prolonged rupture of membrane (PROM> 18 h) | 6 (3.6%) |
| Birth weight (grams), median (IQR) | 3006 (2750–3215) |
| Head circumference (cm), median (IQR) | 33 (32–34.5) |
| 1-min Apgar score, mean ± (SD) | 8 (1) |
| 5-min Apgar score, mean ± (SD) | 9 (1) |
| Neonatal death | 0 |
| Neonates tested for SARS-CoV-2 infection | |
| Positive for COVID-19 | |
| None | 165 (98.8%) |
| Day 5 swab positive test | 2 (1.2%) |
| Day 14 swab positive | 1 (0.6%) |